Lutetium-177 PSMA therapy
Lutetium-177 PSMA therapy is a targeted radiation treatment used primarily in the management of advanced prostate cancer. This targeted therapy is often used in cases where prostate cancer has spread (metastasized) and conventional treatments may be less effective.
Benefits
The benefits of Lutetium-177 PSMA therapy include:
- Targeted and tailored treatment
- Minimal damage to healthy tissues and minimal side effects
- Reduces symptoms
- Effective in advanced cases
- Outpatient procedure
- Effective cancer control
- Promising outcomes
How does it work?
- The treatment involves a radioactive isotope, lutetium-177, that specifically targets prostate-specific membrane antigen (PSMA), a protein abundantly present in prostate cancer cells.
- Lutetium-177 P is administered through an intravenous infusion.
- Once bound to PSMA, lutetium-177 emits beta radiation, delivering localized radiationdirectly to the cancer cells.
- The radiation damages the cancer cells, inhibiting their ability to grow and divide.
Our Doctors
We have some of the best specialists from around the world, they bring years of experience and offer evidence-based treatment to ensure the best care for you.
Our Doctors
We have some of the best specialists from around the world, they bring years of experience and offer evidence-based treatment to ensure the best care for you.
